Westpac Banking Corp’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
PHS
HM
DCM
Westpac Banking Corp's PCRX Position: Q2 2017 in Review
Westpac Banking Corp sold out of Pacira BioSciences (PCRX) in Q2 2017, closing a stake of 7,624 shares — an estimated $348K sold.
Westpac Banking Corp first reported a position in PCRX in Q3 2014 and held it in 11 quarters. The position peaked at $348K in Q1 2017. 196 funds tracked by Wall St. Rank hold PCRX as of Q2 2017.
- Westpac Banking Corp reported no remaining Pacira BioSciences position as of Q2 2017 after selling out during the quarter.
- Westpac Banking Corp sold 7,624 Pacira BioSciences shares in Q2 2017, an estimated $348K.
- Westpac Banking Corp first reported a position in Pacira BioSciences in Q3 2014 and held it in 11 quarters.
- Westpac Banking Corp's Pacira BioSciences position peaked at $348K in Q1 2017.
- 196 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2017.
Based on Westpac Banking Corp's 13F filing for Q2 2017, filed 9 Aug 2017.